The next focusIR Investor Webinar takes places on 14th May with guest speakers from Blue Whale Growth Fund, Taseko Mines, Kavango Resources and CQS Natural Resources fund. Please register here.

Less Ads, More Data, More Tools Register for FREE

Pin to quick picksBraveheart Inv Regulatory News (BRH)

Share Price Information for Braveheart Inv (BRH)

London Stock Exchange
Share Price is delayed by 15 minutes
Get Live Data
Share Price: 6.50
Bid: 6.00
Ask: 7.00
Change: 0.00 (0.00%)
Spread: 1.00 (16.667%)
Open: 0.00
High: 0.00
Low: 0.00
Prev. Close: 6.50
BRH Live PriceLast checked at -

Watchlists are a member only feature

Login to your account

Alerts are a premium feature

Login to your account

Cancellation and grant of options

9 May 2022 13:08

RNS Number : 8123K
Braveheart Investment Group plc
09 May 2022
 

09 May 2022

 

Braveheart Investment Group plc

("Braveheart" or the "Company")

 

Cancellation and grant of options

Braveheart Investment Group (AIM: BRH), announces the cancellation of options over ordinary shares of 2p each in the Company ("Ordinary Shares") issued to two Directors of the Company and the concurrent granting of new options over Ordinary Shares to the same Directors.

 

Background

At the annual general meeting of the Company held on 8 September 2020, shareholders approved the implementation of a share option scheme in order to provide a long-term incentive plan for Directors, employees and consultants of the Company, including those Strategic Investments where Braveheart owns 50% or more of the issued share capital ("the Share Option Plan"). 

 

On 14 October 2021, options were granted over 1,500,000 and 2,000,000 Ordinary Shares to Trevor Brown (CEO) and Vivian Hallam (Executive Director) respectively, at an exercise price of 31.5p per share, being the closing mid-market price of an Ordinary Share on 13 October 2021 (the "Historic Options").

 

[The remuneration committee of the Company ("Remuneration Committee") has determined that, in order to continue to incentivise Trevor Brown and Vivian Hallam without creating further potential dilution for shareholders of the Company, it is appropriate to cancel certain of the Historic Options and issue the same number of new options to the Directors, exercisable at the current share price, as detailed below.]

 

Cancellation of certain Historic Options

The Company has today 9 May 2022 cancelled the following Historic Options:

 

Name

Number of Historic Options Cancelled

Remaining number of Historic Options held

Trevor Brown

750,000

750,000

Vivian Hallam

1,000,000

1,000,000

 

The performance and time related vesting criteria on the remaining Historic Options remain as announced on 14 October 2021.

 

Grant of new options

The Company has [today/on 6 May 2022] granted new options over 1,750,000 Ordinary Shares (the "New Options") as follows:

 

Name

Number of New Options granted

Exercise price

Trevor Brown

750,000

14p

Vivian Hallam

1,000,000

14p

 

The exercise price of the New Options is 14p, being the closing mid-market price of an Ordinary Share on 6 May 2022, the date of grant. The New Options will vest from 6 May 2023 and be exercisable up to 6 May 2032, subject to continued employment and an additional performance related criteria that the closing price of an Ordinary Share must exceed 31.5p, being the exercise price of the Historic Options, for 10 days within any period of 30 days.

Following the cancellation of the Historic Options and grant of the New Options, the Company now has options outstanding over a total of 4,596,000 Ordinary Shares.

 

Details of the transactions can be found in the Notification of Dealing Forms below.

 

1

 

Details of the person discharging managerial responsibilities / person closely associated

 

a)

 

Name

 

 

Trevor Brown

Chief Executive Officer

Vivian Hallam

Executive Director

 

 

2

 

Reason for the notification

 

a)

 

Position/status

 

See 1a) above 

b)

 

Initial notification /Amendment

 

Initial Notification

3

 

Details of the issuer, emission allowance market participant, auction platform, auctioneer or auction monitor

 

a)

 

Name

 

Braveheart Investment Group plc

b)

 

LEI

 

2138006HQ3COMU626I61

4

 

Details of the transaction(s): section to be repeated for (i) each type of instrument; (ii) each type of transaction; (iii) each date; and (iv) each place where transactions have been conducted

 

a)

 

Description of the financial instrument, type of instrument

 

Identification code

 

Ordinary shares of 2 pence each in Braveheart Investment Group plc

 

GB00B13XV322

b)

 

Nature of the transactions

 

Cancellation of options over ordinary shares

c)

 

Price(s) and volume(s)

 

 

Price: Exercise price of 31.5p per share

 

Trevor Brown

750,000

Vivian Hallam

1,000,000

d)

 

Aggregated information

- Aggregated volume

- Price

- Principal amount

 

N/A

 

e)

 

Dates of the transaction

 

6 May 2022

f)

Place of transaction

Outside a trading venue

 

1

 

Details of the person discharging managerial responsibilities / person closely associated

 

a)

 

Name

 

 

Trevor Brown

Chief Executive Officer

Vivian Hallam

Executive Director

2

 

Reason for the notification

 

a)

 

Position/status

 

See 1a) above 

b)

 

Initial notification /Amendment

 

Initial Notification

3

 

Details of the issuer, emission allowance market participant, auction platform, auctioneer or auction monitor

 

a)

 

Name

 

Braveheart Investment Group plc

b)

 

LEI

 

2138006HQ3COMU626I61

4

 

Details of the transaction(s): section to be repeated for (i) each type of instrument; (ii) each type of transaction; (iii) each date; and (iv) each place where transactions have been conducted

 

a)

 

Description of the financial instrument, type of instrument

 

Identification code

 

Ordinary shares of 2 pence each in Braveheart Investment Group plc

 

GB00B13XV322

b)

 

Nature of the transactions

 

Grant of options over ordinary shares

c)

 

Price(s) and volume(s)

 

 

Price:

Exercise price of 14p per share

 

Trevor Brown

750,000

Vivian Hallam

1,000,000

 

 

d)

 

Aggregated information

- Aggregated volume

- Price

- Principal amount

 

 

N/A

 

e)

 

Date of the transaction

 

6 May 2022

f)

Place of transaction

Outside a trading venue

 

 

 

For further information: 

Braveheart Investment Group plc

Tel: 01738 587555

Trevor Brown, Chief Executive Officer

Allenby Capital Limited (Nominated Adviser and Joint Broker)

Tel: 020 3328 5656

David Worlidge / James Reeve / George Payne

Peterhouse Capital Limited (Joint Broker)

Tel: 020 7469 0936

Heena Karani / Lucy Williams

 

 

This information is provided by RNS, the news service of the London Stock Exchange. RNS is approved by the Financial Conduct Authority to act as a Primary Information Provider in the United Kingdom. Terms and conditions relating to the use and distribution of this information may apply. For further information, please contact rns@lseg.com or visit www.rns.com.RNS may use your IP address to confirm compliance with the terms and conditions, to analyse how you engage with the information contained in this communication, and to share such analysis on an anonymised basis with others as part of our commercial services. For further information about how RNS and the London Stock Exchange use the personal data you provide us, please see our Privacy Policy.
 
END
 
 
DSHSSIFEUEESESI
Date   Source Headline
16th Jul 20187:00 amRNSUpdate on fund management business
12th Jul 20187:00 amRNSProposed funding round by Paraytec Limited
10th Jul 201810:44 amRNSHolding(s) in Company
25th Jun 20187:00 amRNSFurther re. Notice of Annual General Meeting
21st Jun 20185:16 pmRNSConfirmation of Posting
20th Jun 201810:30 amRNSAppointment of Joint Broker
18th Jun 20187:02 amRNSNotice of General Meeting
18th Jun 20187:00 amRNSFinal Results
26th Apr 20187:00 amRNSTrading Update
9th Apr 20185:11 pmRNSThird party investment into Gyrometric Systems Ltd
16th Jan 20184:24 pmRNSChange of Registered Office
19th Oct 20177:00 amRNSHalf-year Report
13th Sep 20177:00 amRNSUpdate re. Portfolio investment
1st Sep 20177:00 amRNSRetirement of Director and Total Voting Rights
8th Aug 20177:00 amRNSIssue of Equity
20th Jul 201711:19 amRNSResult of AGM
20th Jul 20177:00 amRNSAGM Statement
21st Jun 20177:00 amRNSFinal Results for the year ended 31 March 2017
7th Jun 20174:08 pmRNSDirectorate Change
20th Apr 20177:00 amRNSTrading Update
9th Jan 20177:00 amRNSStrategic Investment and Trading Update
12th Oct 20167:00 amRNSHalf-year Report
16th Sep 201611:18 amRNSDisposal of interest in Investee Company
2nd Aug 201612:08 pmRNSConditional disposal of interest-Investee Company
29th Jul 201611:13 amRNSStmnt re Share Price Movement
26th Jul 20169:32 amRNSHolding(s) in Company
19th Jul 201611:46 amRNSResult of AGM
19th Jul 20167:00 amRNSAGM Statement
13th Jul 20163:26 pmRNSDirectors' Dealings
8th Jul 20163:07 pmRNSInvestment in Kirkstall Limited
4th Jul 20167:00 amRNSInvestment in Paraytec Limited
23rd Jun 20168:45 amRNSAnnual Results
3rd Mar 20167:00 amRNSChange of Nomad & Broker and Directorate Changes
15th Jan 20169:36 amRNSDirectors' Dealings
8th Jan 201612:36 pmRNSDisposal of interest in WhiteRock Capital Partners
15th Dec 20152:33 pmRNSCompletion of sale of interest in Biopta
27th Nov 20157:00 amRNSDisposal of interest in Investee Company
2nd Nov 20152:35 pmRNSHalf Yearly Report & Disposal
24th Sep 201512:15 pmRNSResult of AGM and Directorate Change
3rd Sep 20157:00 amRNSDirector/PDMR Shareholding
2nd Sep 201512:30 pmRNSPosting of Results and Notice of AGM
24th Aug 20157:00 amRNSPreliminary Results and Board Changes
26th Jun 20152:20 pmRNSChange of address and registered office
6th May 20157:01 amRNSCompletion of restructuring and Directorate change
30th Apr 201511:21 amRNSBraveheart enters into partnership with Seedrs
30th Apr 20157:00 amRNSTermination of partnership
20th Apr 20157:00 amRNSDirectorate Change
23rd Dec 20147:00 amRNSRealisation of Investment
15th Dec 20147:00 amRNSHalf Yearly Report
4th Dec 20147:00 amRNSLondon Co-investment Fund partnership

Due to London Stock Exchange licensing terms, we stipulate that you must be a private investor. We apologise for the inconvenience.

To access our Live RNS you must confirm you are a private investor by using the button below.

Login to your account

Don't have an account? Click here to register.

Quickpicks are a member only feature

Login to your account

Don't have an account? Click here to register.